Invention Grant
- Patent Title: Method for producing renal progenitor cells
-
Application No.: US16912342Application Date: 2020-06-25
-
Publication No.: US11746332B2Publication Date: 2023-09-05
- Inventor: Tatsuya Kawamoto , Yukiko Yamagishi , Kenji Osafune
- Applicant: Astellas Pharma Inc. , KYOTO UNIVERSITY
- Applicant Address: JP Tokyo
- Assignee: Astellas Pharma Inc.,Kyoto University
- Current Assignee: Astellas Pharma Inc.,Kyoto University
- Current Assignee Address: JP Tokyo; JP Kyoto
- Agency: Foley & Lardner LLP
- Priority: JP 15179104 2015.09.11
- The original application number of the division: US15758580
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12N5/071 ; C12N5/10 ; C12Q1/04 ; A61K35/22 ; C12N15/09 ; G01N33/53 ; A01N61/00

Abstract:
A method for acquiring and producing high-purity renal progenitor cells from a renal progenitor cell population into which pluripotent stem cells are induced to differentiate, by identifying a cell surface antigen marker specific to renal progenitor cells. The high-purity renal progenitor cells can be used in regenerative medicine for renal diseases, such as renal failure.
Information query